全文获取类型
收费全文 | 2577篇 |
免费 | 136篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 110篇 |
妇产科学 | 51篇 |
基础医学 | 227篇 |
口腔科学 | 55篇 |
临床医学 | 250篇 |
内科学 | 500篇 |
皮肤病学 | 23篇 |
神经病学 | 204篇 |
特种医学 | 69篇 |
外国民族医学 | 7篇 |
外科学 | 533篇 |
综合类 | 37篇 |
一般理论 | 2篇 |
预防医学 | 179篇 |
眼科学 | 54篇 |
药学 | 188篇 |
中国医学 | 2篇 |
肿瘤学 | 174篇 |
出版年
2023年 | 21篇 |
2022年 | 42篇 |
2021年 | 81篇 |
2020年 | 58篇 |
2019年 | 71篇 |
2018年 | 90篇 |
2017年 | 74篇 |
2016年 | 69篇 |
2015年 | 65篇 |
2014年 | 100篇 |
2013年 | 125篇 |
2012年 | 232篇 |
2011年 | 222篇 |
2010年 | 110篇 |
2009年 | 87篇 |
2008年 | 162篇 |
2007年 | 172篇 |
2006年 | 148篇 |
2005年 | 121篇 |
2004年 | 135篇 |
2003年 | 96篇 |
2002年 | 99篇 |
2001年 | 36篇 |
2000年 | 25篇 |
1999年 | 27篇 |
1998年 | 16篇 |
1997年 | 4篇 |
1996年 | 21篇 |
1995年 | 13篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 12篇 |
1988年 | 20篇 |
1987年 | 14篇 |
1986年 | 9篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1979年 | 9篇 |
1977年 | 3篇 |
1975年 | 8篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1968年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有2721条查询结果,搜索用时 46 毫秒
31.
32.
33.
Nicole Villafane-Ferriol George Van Buren Jose E. Mendez-Reyes Amy L. McElhany Nader N. Massarweh Eric J. Silberfein Cary Hsu Hop S. Tran Cao Carl Schmidt Nicholas J. Zyromski Mary E. Dillhoff Alexandra Roch Evelyn Oliva Alexander C. Smith Qianzi Zhang William E. Fisher 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2018,20(6):514-520
Background
Although used as criterion for early drain removal, postoperative day (POD) 1 drain fluid amylase (DFA) ≤ 5000 U/L has low negative predictive value for clinically relevant postoperative pancreatic fistula (CR-POPF). It was hypothesized that POD3 DFA ≤ 350 could provide further information to guide early drain removal.Methods
Data from a pancreas surgery consortium database for pancreatoduodenectomy and distal pancreatectomy patients were analyzed retrospectively. Those patients without drains or POD 1 and 3 DFA data were excluded. Patients with POD1 DFA ≤ 5000 were divided into groups based on POD3 DFA: Group A (≤350) and Group B (>350). Operative characteristics and 60-day outcomes were compared using chi-square test.Results
Among 687 patients in the database, all data were available for 380. Fifty-five (14.5%) had a POD1 DFA > 5000. Among 325 with POD1 DFA ≤ 5000, 254 (78.2%) were in Group A and 71 (21.8%) in Group B. Complications (35 (49.3%) vs 87 (34.4%); p = 0.021) and CR-POPF (13 (18.3%) vs 10 (3.9%); p < 0.001) were more frequent in Group B.Conclusions
In patients with POD1 DFA ≤ 5000, POD3 DFA ≤ 350 may be a practical test to guide safe early drain removal. Further prospective testing may be useful. 相似文献34.
35.
36.
Dhingra R Pencina MJ Benjamin EJ Levy D Larson MG Meigs JB Rifai N D'Agostino RB Vasan RS 《American journal of hypertension》2004,17(10):891-896
BACKGROUND: Increased sodium intake has been positively associated with high blood pressure (BP) and hypertensive target organ damage, but associations with cardiac structure in nonhypertensive individuals have yielded inconsistent results. We tested the hypothesis that sodium intake is associated with left ventricular (LV) mass and left ventricular hypertrophy (LVH), independent of BP, in the community. METHODS: We analyzed the cross-sectional relationships between urinary sodium excretion and LV measurements in a community-based sample of 2660 Framingham Offspring Study participants (mean age 58 years, 56% women and 44% men). Participants with known coronary artery disease, congestive heart failure, or renal failure as well as those using diuretics were excluded. Urinary sodium excretion was measured on a spot urine sample and was indexed to urinary creatinine. RESULTS: In sex-specific, multivariable linear regression models adjusting for covariates known to influence LV measurements, log urinary sodium was not associated with LV mass, wall thickness, end-diastolic dimensions, or left atrial size in either sex. Urinary sodium was not related to LVH defined as LV mass >/= sex-specific 80th percentile value. In analyses restricted to hypertensive individuals (n = 983, 470 women), urinary sodium was not associated with LV mass or LVH. CONCLUSIONS: In our large community-based sample, urinary sodium excretion was not related to LV mass, function, or hypertrophy. 相似文献
37.
Shifren JL Rifai N Desindes S McIlwain M Doros G Mazer NA 《The Journal of clinical endocrinology and metabolism》2008,93(5):1702-1710
OBJECTIVE: Our objective was to compare the effects of oral vs. transdermal estrogen therapy on C-reactive protein (CRP), IL-6, E- and P-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule-1, serum amyloid A, transferrin, prealbumin, IGF-I, SHBG, thyroxine-binding globulin (TBG), and cortisol-binding globulin (CBG) in naturally menopausal women. DESIGN: This was a randomized, open-label crossover clinical trial. A 6-wk withdrawal from prior hormone therapy (baseline) was followed in randomized order by 12-wk oral conjugated equine estrogens (CEEs) (0.625 mg/d) and 12-wk transdermal estradiol (E2) (0.05 mg/d), with oral micronized progesterone (100 mg/d) given continuously during both regimens. RESULTS: A total of 27 women enrolled, and 25 completed both treatment periods. Nine parameters changed significantly during oral CEE (median percent change from baseline; P value): CRP (192%; P <0.001); E-selectin (-16.3%; P = 0.003); P-selectin (-15.3%; P = 0.012); ICAM-1 (-5%; P = 0.015); transferrin (5.3%; P = 0.024); IGF-I (-30.5%; P < 0.001); SHBG (113%; P < 0.001); TBG (38%; P < 0.001); and CBG (20%; P < 0.001). With transdermal E2, only three parameters changed significantly and to a lesser degree: ICAM-1 (-2.1%; P = 0.04); IGF-I (-12.5%; P < 0.001); and SHBG (2.6%; P = 0.042). During oral CEE the intrasubject changes in CRP correlated strongly with the changes in serum amyloid A (r = 0.805; P < 0.001), and were only weakly associated with the changes in SHBG (r = 0.248; nonsignificant), TBG (0.430; P = 0.031), and CBG (r = 0.072; nonsignificant). The log-log relationship between CRP and IL-6 observed at baseline showed a parallel shift during oral CEE, suggesting an amplified hepatic response or a greater sensitivity to IL-6 stimulation. CONCLUSION: Compared with oral CEE, transdermal E2 exerts minimal effects on CRP and the other inflammation and hepatic parameters. 相似文献
38.
M Sharp K Terada A Wilson S Nader P E Kinchington W T Ruyechan J Hay A M Arvin 《The Journal of infectious diseases》1992,165(5):852-858
The cytotoxic T lymphocyte (CTL) response was evaluated in adults given live attenuated varicella vaccine, using target cells expressing varicella-zoster virus (VZV) immediate-early protein (IE62) or VZV glycoproteins gpI, gpIV, or gpV to determine viral protein specificity. The frequency of CTL that recognized IE62 was 1:171,000 +/- 46,000 SE in subjects tested 10 days to 8 weeks after the initial vaccine dose; the induction of CTL specific for gpI was equivalent. CTL recognition of VZV proteins was mediated by CD4+ or CD8+ cells. CTL recognition of IE62 and gpIV persisted in vaccinees (tested approximately 4 years later) and was comparable to that in the naturally immune. The mean frequency of CTL specific for gpV was lower (but not significantly) in vaccinees than in naturally immune subjects. Assay of responder cell frequencies showed persistence of equivalent numbers of T lymphocytes that recognized IE62 and gpI in vaccinees and naturally immune subjects. Immunization with this vaccine elicited memory T lymphocyte responses to VZV comparable to those induced by natural infection. 相似文献
39.
Nader Kim El-Mallawany Choladda V. Curry Carl E. Allen 《British journal of haematology》2022,196(1):31-44
Epstein–Barr virus (EBV) is a ubiquitous herpesvirus with rare but severe potential for lymphoproliferative complications. EBV is associated with a variety of presentations of haemophagocytic lymphohistiocytosis (HLH). HLH is a life-threatening hyperinflammatory syndrome that can occur in patients with genetic defects associated with dysregulation of the immune response (familial HLH) or arise in patients with underlying infection or malignancy (non-familial or secondary HLH). EBV can both serve as the incidental trigger of familial HLH or as the driving factor in patients with selective inherited vulnerability (e.g. X-linked lymphoproliferative disease). Alternatively, acute infection can idiosyncratically cause non-neoplastic HLH in patients without inherited predisposition (i.e. secondary HLH), while EBV-associated T/natural killer (NK)-cell lymphoproliferative disorders and lymphomas can cause neoplasia-associated HLH. The present review will discern between EBV-associated familial and non-familial HLH and highlight diagnostic and therapeutic considerations. Non-familial EBV-associated HLH is a major diagnostic dilemma, as it represents a diverse spectrum of disease ranging from highly curable (non-neoplastic EBV-HLH) to indolent but incurable (chronic active EBV) to acutely fatal (systemic EBV-positive T-cell lymphoma of childhood). Increased clinical awareness and understanding of this rare and potentially devastating subset of EBV-related complications is desperately needed to improve survival for patients with neoplasia-associated HLH. 相似文献
40.